Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Swank, Inc. (SNKI)
|
Add to portfolio |
|
|
|
| Price: |
$9.98
| | Metrics |
| OS: |
5.55
|
M
| |
13
|
% ROE
|
| Market cap: |
$55.4
|
M
| |
10
|
% ROIC
|
|
Net debt:
|
$11.1
|
M
| |
1.2
|
x Debt/EBITDA
|
|
EV:
|
$66.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$9.0
|
M
| |
7.4
|
x EV/EBITDA
|
|
EBIT
|
$8.6
|
M
| |
7.7
|
x EV/EBIT
|
| EPS |
$0.88
| |
11.3
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 138.6 | 132.7 | 114.8 | 114.0 | 128.6 | 119.1 | 97.9 | 93.3 |
| Revenue growth | 4.5% | 15.6% | 0.7% | -11.4% | 8.0% | 21.6% | 5.0% | -1.6% |
| Cost of goods sold | 92.2 | 91.7 | 78.4 | 78.1 | 85.8 | 77.7 | 65.0 | 62.6 |
| Gross profit | 46.5 | 41.0 | 36.4 | 35.8 | 42.8 | 41.4 | 32.9 | 30.7 |
| Gross margin | 33.5% | 30.9% | 31.7% | 31.4% | 33.3% | 34.8% | 33.6% | 32.9% |
| Selling, general and administrative | 36.3 | 34.5 | 32.4 | 33.5 | 32.6 | 30.0 | 28.0 | 28.3 |
| EBIT | 10.1 | 6.5 | 4.0 | 4.3 | 10.2 | 11.4 | 4.9 | 3.2 |
| EBIT margin | 7.3% | 4.9% | 3.5% | 3.8% | 7.9% | 9.6% | 5.0% | 3.4% |
| Pre-tax income | 9.8 | 6.1 | 3.6 | 3.5 | 8.5 | 9.8 | 3.6 | 1.6 |
| Income taxes | 3.9 | 1.9 | 1.9 | 1.4 | 3.6 | -4.2 | 0.0 | 0.0 |
| Tax rate | 39.4% | 31.4% | 51.1% | 39.7% | 42.0% | | 0.8% | 0.0% |
| Earnings from continuing ops | 5.9 | 4.2 | 1.8 | 2.1 | 4.9 | 14.0 | 3.6 | 1.6 |
| Earnings from discontinued ops | | | | | | | | 1.6 |
| Net income | 5.9 | 4.2 | 1.8 | 2.1 | 4.9 | 14.0 | 3.6 | 3.1 |
| Net margin | 4.3% | 3.1% | 1.5% | 1.8% | 3.8% | 11.7% | 3.7% | 3.4% |
| |
| Diluted EPS | $1.06 | $0.74 | $0.31 | $0.35 | $0.81 | $2.36 | $0.59 | $0.26 |
| Shares outstanding (diluted) | 5.6 | 5.6 | 5.7 | 6.0 | 6.1 | 5.9 | 6.1 | 6.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|